| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.43 | 0.1 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |